Phase II Clinical Trial of KJ101in the Treatment of Deep II Degree Burns
Status:
RECRUITING
Trial end date:
2026-08-29
Target enrollment:
Participant gender:
Summary
This multicentre, randomised, double-blind, dose-finding, active- and placebo-controlled Phase II clinical trial will evaluate the safety, efficacy, pharmacokinetic profile, and immunogenicity of KJ101 for the debridement of deep second-degree burns. The trial will provide supporting evidence for subsequent Phase III trials.